Literature DB >> 17289046

Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.

Tamás Atlasz1, Norbert Babai, Péter Kiss, Dóra Reglodi, Andrea Tamás, Krisztina Szabadfi, Gábor Tóth, Orsolya Hegyi, Andrea Lubics, Róbert Gábriel.   

Abstract

Pituitary adenylate cyclase activating popypeptide (PACAP) is a pleiotropic neuropeptide, exerting neurotrophic and neuroprotective effects in numerous models of in vitro and in vivo nervous injuries. The aim of the present study was to investigate whether PACAP is neuroprotective in ischemic retinal damage. Adult male Wistar rats underwent bilateral carotid occlusion and PACAP was administered unilaterally into the vitreous body immediately following carotid occlusion. Retinas were analyzed three weeks after the injury. It was found that bilateral carotid occlusion led to a severe degeneration of all retinal layers. PACAP treatment significantly ameliorated the carotid occlusion-induced retinal damage: the overall thickness of the retina was significantly more than in control carotid occluded animals and the morphological characteristics of the photoreceptors showed nearly normal appearance. The outer plexiform layer remained discernible and the inner and outer nuclear layers were significantly thicker than in control animals. In summary, our present study provides evidence, for the first time, that PACAP attenuates ischemic retinal degeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17289046     DOI: 10.1016/j.ygcen.2006.12.022

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  32 in total

1.  Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress.

Authors:  E Fabian; D Reglodi; L Mester; A Szabo; K Szabadfi; A Tamas; G Toth; K Kovacs
Journal:  J Mol Neurosci       Date:  2012-05-29       Impact factor: 3.444

2.  Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells.

Authors:  Laszlo Mester; Krisztina Kovacs; Boglarka Racz; Izabella Solti; Tamas Atlasz; Krisztina Szabadfi; Andrea Tamas; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-07-20       Impact factor: 3.444

3.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

4.  Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.

Authors:  Tamas Atlasz; Krisztina Szabadfi; Peter Kiss; Zsuzsanna Marton; Monika Griecs; Levente Hamza; Valeria Gaal; Zsolt Biro; Andrea Tamas; Gabor Hild; Miklos Nyitrai; Gabor Toth; Dora Reglodi; Robert Gabriel
Journal:  J Mol Neurosci       Date:  2010-06-03       Impact factor: 3.444

5.  Comparison of intestinal warm ischemic injury in PACAP knockout and wild-type mice.

Authors:  Andrea Ferencz; Peter Kiss; Gyorgy Weber; Zsuzsanna Helyes; Norihito Shintani; Akemichi Baba; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-04-13       Impact factor: 3.444

6.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

7.  The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Authors:  A Vaczy; D Reglodi; T Somoskeoy; K Kovacs; E Lokos; E Szabo; A Tamas; T Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

8.  PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.

Authors:  Timea Kvarik; Barbara Mammel; Dora Reglodi; Krisztina Kovacs; Dora Werling; Brigitta Bede; Alexandra Vaczy; Eszter Fabian; Gabor Toth; Peter Kiss; Andrea Tamas; Tibor Ertl; Judit Gyarmati; Tamas Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

9.  Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?

Authors:  Donald R Staines; Ekua W Brenu; Sonya Marshall-Gradisnik
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 10.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.